Modern approaches to the prevention of pneumococcal infection

Abstract

Pneumococcal diseases are widespread all over the world. According to WHO, every year14.5 million (11,1--18 million) of children under the age of 5 years suffer from the diseases, while the number of deaths due to pneumococcal infection reaches 826 thousand (582--926 thousand), or 11% of all deaths among children in this age group. At the same time, pneumococci may be part of the normal flora of the upper respiratory tract contributing to the bacteria carrying capacity. The carrying may be asymptomatic but may result in contact or hematogenous penetration of microorganisms from nasopharynx to other organs. This is largely determined by the pneumococcal serotype.

Keywords

• пневмококковая инфекция
• вакцинопрофилактика
• полисахаридная пневмококковая вакцина
• пневмококковая конъюгированная вакцина
• pneumococcal infection
• vaccination
• pneumococcal polysaccharide vaccine
• pneumococcal conjugate vaccine